Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
gut microbiota1104 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A18073 | 27367724 | Nutrients | Beneficial Effect of Synbiotic Supplementation on Hepatic Steatosis and Anthropometric Parameters, But Not on Gut Permeability in a Population with Nonalcoholic Steatohepatitis. | 2016 | Details |
| A18085 | 30695468 | Rinsho Byori | [Progress in the Management of NAFLD/NASH]. | 2016 | Details |
| A18120 | 27342212 | Gastroenterology | Loss of Junctional Adhesion Molecule A Promotes Severe Steatohepatitis in Mice on a Diet High in Saturated Fat, Fructose, and Cholesterol. | 2016 | Details |
| A18139 | 27324067 | Metabolism | Nonalcoholic fatty liver disease and obstructive sleep apnea. | 2016 | Details |
| A18202 | 27288420 | Am J Physiol Gastrointest Liver Physiol | Gut microbiota are linked to increased susceptibility to hepatic steatosis in low-aerobic-capacity rats fed an acute high-fat diet. | 2016 | Details |
| A18226 | 27273788 | Int J Cancer | Dysregulated hepatic bile acids collaboratively promote liver carcinogenesis. | 2016 | Details |
| A18227 | 27273168 | Nat Rev Gastroenterol Hepatol | The role of the gut microbiota in NAFLD. | 2016 | Details |
| A18278 | 27247565 | Gastroenterol Res Pract | The Pathogenesis of Nonalcoholic Fatty Liver Disease: Interplay between Diet, Gut Microbiota, and Genetic Background. | 2016 | Details |
| A18336 | 27197843 | Br J Nutr | Preventive effects of citrulline on Western diet-induced non-alcoholic fatty liver disease in rats. | 2016 | Details |
| A18341 | 27196572 | Gut | Hepatocyte MyD88 affects bile acids, gut microbiota and metabolome contributing to regulate glucose and lipid metabolism. | 2016 | Details |
| A18350 | 27187452 | Nutrients | Gut Microbiota and Metabolic Health: The Potential Beneficial Effects of a Medium Chain Triglyceride Diet in Obese Individuals. | 2016 | Details |
| A18351 | 27187365 | Int J Mol Sci | Non-Alcoholic Fatty Liver Disease and Extra-Hepatic Cancers. | 2016 | Details |
| A18432 | 27142672 | Dig Dis Sci | Impact of Hypocaloric Hyperproteic Diet on Gut Microbiota in Overweight or Obese Patients with Nonalcoholic Fatty Liver Disease: A Pilot Study. | 2016 | Details |
| A18463 | 27111464 | J Appl Microbiol | Gut microbiota-associated bile acid deconjugation accelerates hepatic steatosis in ob/ob mice. | 2016 | Details |
| A18473 | 27105827 | Nutr J | Pathophysiological role of host microbiota in the development of obesity. | 2016 | Details |
| A18509 | 27085070 | Biochim Biophys Acta | Unique microbial-derived volatile organic compounds in portal venous circulation in murine non-alcoholic fatty liver disease. | 2016 | Details |
| A18545 | 27063268 | Clin Liver Dis | Nonalcoholic Fatty Liver Disease and the Gut Microbiome. | 2015 | Details |
| A18574 | 27051672 | Biomed Res Int | Perilla Oil Has Similar Protective Effects of Fish Oil on High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease and Gut Dysbiosis. | 2016 | Details |
| A18591 | 27043550 | Int J Mol Sci | Diet, Microbiota, Obesity, and NAFLD: A Dangerous Quartet. | 2016 | Details |
| A18611 | 27036035 | Oncotarget | Distinctly altered gut microbiota in the progression of liver disease. | 2016 | Details |
| A18624 | 27028797 | Hepatology | Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta-omics-based approach. | 2016 | Details |
| A18632 | 27023533 | Int J Mol Sci | Gut Microbiota and Lifestyle Interventions in NAFLD. | 2016 | Details |
| A18633 | 28868449 | GE Port J Gastroenterol | Microbiota Modulation With Synbiotic Decreases Liver Fibrosis in a High Fat Choline Deficient Diet Mice Model of Non-Alcoholic Steatohepatitis (NASH). | 2016 | Details |
| A18642 | 27018382 | Biochem Biophys Res Commun | Protective effects of Lactobacillus rhamnosus GG against dyslipidemia in high-fat diet-induced obese mice. | 2016 | Details |
| A18683 | 26999104 | Int J Mol Sci | Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanism and Application of Metabolomics. | 2016 | Details |
| A18817 | 26923892 | Arch Iran Med | Modulation of Gut Microbiota by Berberine Improves Steatohepatitis in High-Fat Diet-Fed BALB/C Mice. | 2016 | Details |
| A18833 | 26912150 | Diabetes Metab J | Novel Molecular Mechanisms in the Development of Non-Alcoholic Steatohepatitis. | 2016 | Details |
| A18857 | 26898658 | Dig Dis Sci | Gut Microbiota of Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A18865 | 26894897 | Cell Mol Life Sci | Pathogenesis of nonalcoholic steatohepatitis. | 2016 | Details |
| A19006 | 26823198 | Metabolism | The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). | 2016 | Details |
| A19014 | 26818807 | Sci Rep | Involvement of resistin-like molecule β in the development of methionine-choline deficient diet-induced non-alcoholic steatohepatitis in mice. | 2016 | Details |
| A19210 | 26702135 | Am J Physiol Gastrointest Liver Physiol | Deficiency of intestinal mucin-2 protects mice from diet-induced fatty liver disease and obesity. | 2015 | Details |
| A19211 | 26699443 | J Gastroenterol Hepatol | Red pitaya betacyanins protects from diet-induced obesity, liver steatosis and insulin resistance in association with modulation of gut microbiota in mice. | 2016 | Details |
| A19233 | 26682925 | Biochem Biophys Res Commun | DSS colitis promotes tumorigenesis and fibrogenesis in a choline-deficient high-fat diet-induced NASH mouse model. | 2015 | Details |
| A19275 | 26663004 | Hepatobiliary Pancreat Dis Int | Gut microbiota and non-alcoholic fatty liver disease. | 2015 | Details |
| A19310 | 26635079 | BMC Gastroenterol | Gut microbiota manipulation with prebiotics in patients with non-alcoholic fatty liver disease: a randomized controlled trial protocol. | 2015 | Details |
| A19372 | 26600967 | World J Gastrointest Pathophysiol | Starring role of toll-like receptor-4 activation in the gut-liver axis. | 2015 | Details |
| A19376 | 26600078 | Hepatology | The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota. | 2016 | Details |
| A19460 | 26556989 | World J Gastroenterol | Gut microbiota and host metabolism in liver cirrhosis. | 2015 | Details |
| A19490 | 26524607 | Scand J Immunol | Effect of Lipopolysaccharide on the Progression of Non-Alcoholic Fatty Liver Disease in High Caloric Diet-Fed Mice. | 2016 | Details |
| A19577 | 26474417 | PLoS One | Naturally Occurring Stilbenoid TSG Reverses Non-Alcoholic Fatty Liver Diseases via Gut-Liver Axis. | 2015 | Details |
| A19623 | 26449892 | Nutr Clin Pract | Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A19693 | 26406351 | J Dig Dis | Nonalcoholic fatty liver disease - current status and future directions. | 2015 | Details |
| A19750 | 26378643 | Semin Liver Dis | The Gut Microbiota and Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A19758 | 26375281 | PLoS One | Co-Administration of Cholesterol-Lowering Probiotics and Anthraquinone from Cassia obtusifolia L. Ameliorate Non-Alcoholic Fatty Liver. | 2015 | Details |
| A19808 | 26338727 | Gut | The gut microbiota and host health: a new clinical frontier. | 2015 | Details |
| A19831 | 26318867 | Transl Res | Targeting gut-liver axis for the treatment of nonalcoholic steatohepatitis: translational and clinical evidence. | 2015 | Details |
| A19848 | 26310987 | Int J Cardiol | Mechanistic link between nonalcoholic fatty liver disease and cardiometabolic disorders. | 2015 | Details |
| A19954 | 26242295 | Trials | The link between obesity and vitamin D in bariatric patients with omega-loop gastric bypass surgery - a vitamin D supplementation trial to compare the efficacy of postoperative cholecalciferol loading (LOAD): study protocol for a randomized controlled trial. | 2015 | Details |
| A19994 | 26216400 | J Proteome Res | Effects of Dietary Different Doses of Copper and High Fructose Feeding on Rat Fecal Metabolome. | 2015 | Details |
| A20028 | 26200028 | Rev Esp Quimioter | Maraviroc modifies gut microbiota composition in a mouse model of obesity: a plausible therapeutic option to prevent metabolic disorders in HIV-infected patients. | 2015 | Details |
| A20100 | 26155043 | J Clin Exp Hepatol | The Riddle of Nonalcoholic Fatty Liver Disease: Progression From Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis. | 2015 | Details |
| A20106 | 26151226 | Clin Biochem | Gut-liver axis, nutrition, and non-alcoholic fatty liver disease. | 2015 | Details |
| A20118 | 26143342 | Dig Dis Sci | Lactobacillus paracasei Induces M2-Dominant Kupffer Cell Polarization in a Mouse Model of Nonalcoholic Steatohepatitis. | 2015 | Details |
| A20194 | 26090468 | Biomed Res Int | Gut Microbiota: Association with NAFLD and Metabolic Disturbances. | 2015 | Details |
| A20237 | 26070860 | Expert Rev Gastroenterol Hepatol | Physiology and pathophysiology of liver lipid metabolism. | 2015 | Details |
| A20241 | 26067771 | Hepatol Int | The gut microbiota of nonalcoholic fatty liver disease: current methods and their interpretation. | 2015 | Details |
| A20242 | 26067236 | Elife | The genetic architecture of NAFLD among inbred strains of mice. | 2015 | Details |
| A20272 | 26052375 | World J Hepatol | Pathophysiological mechanisms involved in non-alcoholic steatohepatitis and novel potential therapeutic targets. | 2015 | Details |
| A20289 | 26045268 | Dig Dis | Relationship between Obesity, Gut Microbiome and Hepatocellular Carcinoma Development. | 2015 | Details |
| A20382 | 26000656 | Future Microbiol | Systematic review on intervention with prebiotics/probiotics in patients with obesity-related nonalcoholic fatty liver disease. | 2015 | Details |
| A20449 | 25956735 | Med Hypotheses | Is nonalcoholic fatty liver disease an endogenous alcoholic fatty liver disease? - A mechanistic hypothesis. | 2015 | Details |
| A20547 | 25894944 | Curr Diab Rep | Nonalcoholic fatty liver disease and type 2 diabetes: common pathophysiologic mechanisms. | 2015 | Details |
| A20557 | 25889212 | J Transl Med | Docosahexaenoic acid and non-alcoholic fatty liver disease in obese children: a novel approach? | 2015 | Details |
| A20563 | 25882223 | Curr Drug Targets | Targeting the Gut Microbiota for the Treatment of Non-Alcoholic Fatty Liver Disease. | 2015 | Details |
| A20599 | 25864208 | Ann Hepatol | Obesity as a cause of hepatocellular carcinoma. | 2016 | Details |
| A20621 | 25848479 | World J Hepatol | Probiotics as a complementary therapeutic approach in nonalcoholic fatty liver disease. | 2015 | Details |
| A20840 | 25697178 | Br J Nutr | Dietary trans-10, cis-12-conjugated linoleic acid alters fatty acid metabolism and microbiota composition in mice. | 2015 | Details |
| A20854 | 25684933 | World J Gastroenterol | Gut microbiota and liver diseases. | 2015 | Details |
| A20921 | 25644696 | Sci Rep | Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease. | 2015 | Details |
| A21062 | 27682116 | Microorganisms | Gut Microbiota and Host Reaction in Liver Diseases. | 2015 | Details |
| A21069 | 27188459 | Nat Rev Dis Primers | Nonalcoholic fatty liver disease. | 2015 | Details |
| A21079 | 25548472 | World J Gastroenterol | Intestinal microbiota and type 2 diabetes: from mechanism insights to therapeutic perspective. | 2014 | Details |
| A21174 | 25500885 | J Clin Invest | Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease. | 2014 | Details |
| A21205 | 25479248 | Nutrients | The role of intestinal bacteria overgrowth in obesity-related nonalcoholic fatty liver disease. | 2014 | Details |
| A21217 | 25473159 | World J Gastroenterol | Gut microbiota and metabolic syndrome. | 2014 | Details |
| A21226 | 25469019 | World J Gastroenterol | Effect of probiotic administration on the intestinal microbiota, current knowledge and potential applications. | 2014 | Details |
| A21284 | 27356366 | Bull Acad Natl Med | [Not Available]. | 2014 | Details |
| A21294 | 25428903 | Am J Physiol Gastrointest Liver Physiol | Mosapride citrate improves nonalcoholic steatohepatitis with increased fecal lactic acid bacteria and plasma glucagon-like peptide-1 level in a rodent model. | 2014 | Details |
| A21333 | 25400436 | World J Gastroenterol | Gut-liver axis and probiotics: their role in non-alcoholic fatty liver disease. | 2014 | Details |
| A21388 | 25353664 | Nutrients | Non-alcoholic fatty liver disease in children: focus on nutritional interventions. | 2014 | Details |
| A21563 | 25225347 | Adv Nutr | Modulation of the gut microbiota by nutrients with prebiotic and probiotic properties. | 2014 | Details |
| A21847 | 25003671 | Turk J Gastroenterol | Role of gut microbiota: obesity and NAFLD. | 2014 | Details |
| A21912 | 24966608 | World J Gastroenterol | Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease. | 2014 | Details |
| A22088 | 24829682 | Middle East J Dig Dis | Probiotics and Nonalcoholic Fatty liver Disease. | 2013 | Details |
| A22130 | 24797416 | Sci Rep | Oral pathobiont induces systemic inflammation and metabolic changes associated with alteration of gut microbiota. | 2014 | Details |
| A22151 | 24786095 | Int J Mol Sci | Molecular mechanisms and new treatment strategies for non-alcoholic steatohepatitis (NASH). | 2014 | Details |
| A22228 | 24738701 | Aliment Pharmacol Ther | Randomised clinical trial: The beneficial effects of VSL#3 in obese children with non-alcoholic steatohepatitis. | 2014 | Details |
| A22244 | 24726273 | Clin Res Hepatol Gastroenterol | Pediatric non-alcoholic fatty liver disease: recent advances. | 2014 | Details |
| A22271 | 24702768 | FEBS J | Revisiting the metabolic syndrome and paving the way for microRNAs in non-alcoholic fatty liver disease. | 2014 | Details |
| A22402 | 24613361 | J Hepatol | Gut-adipose tissue axis in hepatic fat accumulation in humans. | 2014 | Details |
| A22413 | 24604038 | Indian J Med Res | Probiotic foods: can their increasing use in India ameliorate the burden of chronic lifestyle disorders? | 2014 | Details |
| A22468 | 24547986 | J Gastroenterol Hepatol | Gut microbiota and liver disease. | 2014 | Details |
| A22519 | 24495527 | Proc Nutr Soc | 'The way to a man's heart is through his gut microbiota'--dietary pro- and prebiotics for the management of cardiovascular risk. | 2014 | Details |
| A22591 | 24438438 | BMC Public Health | Effect of aerobic exercise and low carbohydrate diet on pre-diabetic non-alcoholic fatty liver disease in postmenopausal women and middle aged men--the role of gut microbiota composition: study protocol for the AELC randomized controlled trial. | 2014 | Details |
| A22623 | 24402126 | Int J Mol Sci | Meta-omic platforms to assist in the understanding of NAFLD gut microbiota alterations: tools and applications. | 2014 | Details |
| A22679 | 26417275 | EXCLI J | Non-alcoholic fatty liver disease, diet and gut microbiota. | 2014 | Details |
| A22703 | 25744638 | Nihon Rinsho Meneki Gakkai Kaishi | [Cellular senescence and chronic inflammation]. | 2014 | Details |
| A22807 | 24290319 | Rev Gastroenterol Mex | [Gut microbiota in health and disease]. | 2013 | Details |
| A22830 | 24275855 | Curr Opin Oncol | Contributions of metabolic dysregulation and inflammation to nonalcoholic steatohepatitis, hepatic fibrosis, and cancer. | 2014 | Details |